Hot Topic Commentary on COVID-19

Ah-Ng Kong; Andy T Y Lau; Luigi Brunetti

doi:10.1007/s40495-020-00215-8

Hot Topic Commentary on COVID-19

Curr Pharmacol Rep. 2020;6(3):53-55. doi: 10.1007/s40495-020-00215-8. Epub 2020 May 11.

Authors

Ah-Ng Kong¹, Andy T Y Lau², Luigi Brunetti^{3

4}

Affiliations

¹ Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers University, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854 USA.
² Laboratory of Cancer Biology and Epigenetics, Department of Cell Biology and Genetics, Shantou University Medical College, Shantou, 515041 Guangdong China.
³ Department of Pharmacy Practice, Ernest Mario School of Pharmacy, Piscataway, NJ 08854 USA.
⁴ Robert Wood Johnson University Hospital Somerset, Somerville, NJ 08876 USA.

Abstract

The recent pandemic outbreak of COVID-19 (severe acute respiratory syndrome coronavirus 2; SARS-CoV-2) worldwide caught the health care systems in every country around the world by storm and without a proper defense mechanism to cope and control such a pandemic. In this special Theme issue, we would like to discuss the latest treatment modalities available around the world in tackling this dreadful disease.

Keywords: COVID-19; Coronavirus; Drugs for COVID-19; SARS-CoV-2.

Publication types

Review

Abstract

Publication types

Grants and funding